10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
PLEASANTON, Calif., Oct. 1, 2024 /PRNewswire/ -- At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy,...
Pharmaceutical
Premise Health Digital Wellness Center Receives Accreditation from Accreditation Association for Ambulatory Health Care
Premise's Digital Wellness Center is the first virtual platform to receive accreditation from AAAHC BRENTWOOD, Tenn., Oct. 1, 2024 /PRNewswire/...
Scout Appoints Moisha Platto as Chief Executive Officer
DALLAS, Oct. 1, 2024 /PRNewswire/ -- Scout, a leader in services and technology for the biopharmaceutical industry, announces the appointment of...
EDETEK has appointed Dr. Shakthi Kumar, a leading industry executive, as its Chief Strategy and Business Officer
Dr. Shakthi Kumar, an industry leader in Life Sciences and Healthcare, has joined EDETEK's executive leadership team. Dr. Kumar will...
Axtria Recognized in 2024 Gartner® Hype Cycle™ for Life Science Commercial Operations
BERKELEY HEIGHTS, N.J., Oct. 1, 2024 /PRNewswire/ -- Axtria, a global leader in cloud software and data analytics for the...
NextPlat Announces Completion of Merger and Business Combination with Progressive Care Inc. as Company Focuses on Growth in Healthcare, Technology and Personal Wellness Markets
Progressive Care Stock to Cease Trading Today, October 1, 2024 COCONUT GROVE, Fla., Oct. 1, 2024 /PRNewswire/ -- NextPlat Corp (NASDAQ:...
ClariMed Inc. Strengthens Leadership Team with Joe Dobkin as New VP of Services
CHADDS FORD, Pa., Oct. 1, 2024 /PRNewswire/ -- ClariMed, Inc., a global leader in human-centered medical device development and regulatory...
Astrix Accelerates Global Expansion with Enhanced Presence in Europe
Expanded European presence aims to meet increasing global demand from the life science industry. RED BANK, N.J., Oct. 1, 2024...
Palatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
Obesity: Phase 2 Clinical Study with Melanocortin-4 Receptor (MC4R) Agonist plus Glucagon Like Peptide-1 (GLP-1)Patient Dosing Commenced 3Q Calendar Year...
Qnovia, Inc. announces FDA clearance of IND application for lead asset RespiRx™ Nicotine Inhaler as a prescription smoking cessation therapy
- Phase 1 clinical trial for smoking cessation expected to dose first patient in 4Q 2024 - - The study...
Chasing efficiency and digital maturity: CRB’s new Horizons report finds biopharma manufacturers going all-in on digitalization, continuous manufacturing and more
Meeting patient demand for breakthrough drugs and therapies requires new efficiencies on the manufacturing floor, and the industry is responding...
OPTEL and Worximity Join Forces to Boost Line Performance with Real-Time OEE Solutions
QUÉBEC CITY, Oct. 1, 2024 /PRNewswire/ - OPTEL, a global leader in traceability and vision systems, and Worximity, a leading...
New Report: Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome
WASHINGTON, DC / ACCESSWIRE / October 1, 2024 / Boosting research investment into the health and wellbeing of adults with...
Lexaria Appoints Michael Shankman as Chief Financial Officer
KELOWNA, BC / ACCESSWIRE / October 1, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a...
Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT’s 2024 Advancing Gene + Cell Therapies for Cancer Conference
Marlborough, Massachusetts--(Newsfile Corp. - October 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary...
Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP...
Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer
Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of...
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of...
The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding...
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
SEATTLE and VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...